Nicotine metabolism largely normally takes position inside the liver. Consequently, when nicotine is administered throughout the GI program, it undergoes initially-go metabolism through the liver, bringing about a bioavailability of only about twenty%. This process inherently decreases the bioavailability of nicotine in the method and should trigge